François-Xavier Roger
Director of Finance/CFO at SANOFI
Profile
Presently, François-Xavier Michel Marie Roger holds the position of Chief Financial Officer & Executive Vice President of Nestlé SA. He is also on the board of Nestlé Health Science SA and Member of Les Prés Fleuris-Stiftung. In the past he held the position of Vice President-Corporate Finance at Danone SA and Chief Financial Officer at Danone Asia Pte Ltd. (a subsidiary of Danone SA), Chief Financial Officer & Director at Takeda Pharmaceutical Co., Ltd., Finance Director at Hoechst Marion Roussel SA de CV, Chief Financial Officer & Senior Executive VP at Millicom International Cellular SA, Vice President-Finance at Aventis Pharma Japan and Senior Controller at Roussel Uclaf SA. Mr. Roger received an MBA from The Ohio State University and a graduate degree from Audencia.
Latest news about François-Xavier Roger
François-Xavier Roger active positions
Companies | Position | Start |
---|---|---|
SANOFI | Director of Finance/CFO | 01/04/2024 |
Les Prés Fleuris-Stiftung | Corporate Officer/Principal | - |
Former positions of François-Xavier Roger
Companies | Position | End |
---|---|---|
Sandoz AG
![]() Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a leader in generic and biosimilar medicines. The company is based in Basel, Switzerland. Sandoz traces its heritage back to 1886 and has a history of breakthroughs, including the world's first oral penicillin in 1951 and the world's first biosimilar in 2006. With a sales achievement of USD 9.1 billion in 2022 and a portfolio of approximately 1,500 products, Sandoz provides 800 million patient treatments annually, addressing diseases from the common cold to cancer. Richard Saynor has been the CEO of the Swiss company since 2019. | Director/Board Member | 31/03/2024 |
SANDOZ GROUP AG | Director/Board Member | 31/03/2024 |
NESTLÉ S.A. | Director of Finance/CFO | 01/03/2024 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Director of Finance/CFO | 01/01/2015 |
MILLICOM INTERNATIONAL CELLULAR S.A. | Director of Finance/CFO | 31/08/2013 |
Training of François-Xavier Roger
The Ohio State University | Masters Business Admin |
Audencia | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 7 |
---|---|
BRITANNIA INDUSTRIES LIMITED | Consumer Non-Durables |
MILLICOM INTERNATIONAL CELLULAR S.A. | Communications |
DANONE | Consumer Non-Durables |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
NESTLÉ S.A. | Consumer Non-Durables |
SANDOZ GROUP AG | Health Technology |
SANOFI | Health Technology |
Private companies | 8 |
---|---|
Comvik International (Vietnam) AB
![]() Comvik International (Vietnam) AB Telecommunications EquipmentElectronic Technology Comvik International (Vietnam) AB engages in the development, production, and sale of equipment and services in the field of radio and telecommunications. The company was founded in 1993 and is headquartered in Stockholm, Sweden. | Electronic Technology |
Les Prés Fleuris-Stiftung | |
Nestle Health Science SA
![]() Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Health Technology |
Danone Asia Pte Ltd.
![]() Danone Asia Pte Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Part of Danone SA, Danone Asia Pte Ltd. is a Singaporean company that produces and distributes food. The company is based in Singapore, Singapore. Danone Asia was acquired by Danone SA from Exor SA on May 01, 1998. | Consumer Non-Durables |
Aventis Pharma Japan
![]() Aventis Pharma Japan Miscellaneous Commercial ServicesCommercial Services Aventis Pharma Japan researches, manufactures, and distributes pharmaceutical drugs. It offers prescription drugs, human vaccines, and therapeutic proteins businesses. The company is headquartered in Tokyo, Japan. | Commercial Services |
Hoechst Marion Roussel SA de CV | |
Roussel Uclaf SA | Health Technology |
Sandoz AG
![]() Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a leader in generic and biosimilar medicines. The company is based in Basel, Switzerland. Sandoz traces its heritage back to 1886 and has a history of breakthroughs, including the world's first oral penicillin in 1951 and the world's first biosimilar in 2006. With a sales achievement of USD 9.1 billion in 2022 and a portfolio of approximately 1,500 products, Sandoz provides 800 million patient treatments annually, addressing diseases from the common cold to cancer. Richard Saynor has been the CEO of the Swiss company since 2019. | Health Technology |
- Stock Market
- Insiders
- François-Xavier Roger